PharmiWeb.com - Global Pharma News & Resources
04-Feb-2021

HPV and Pap Testing Market 2020 : Current Scenario, Product Category, Volume Analysis, Future Investments and Projected to Witness a Rapid Growth by Forecast to 2026

HPV stands for human papillomavirus, which constitutes a group of over 150 related viruses. Every HPV virus has number or type. HPV’s are attracted to specific cell type known as squamous epithelial cells and these viruses can live only in these cells. Some of the human papillomavirus cause non-cancerous tumors, while others can lead to cancer such as cancer of the cervix, vagina, vulva, anus, penis, and parts of mouth and throat that comprises moist skin in the body. These types of HPVs are considered to be mucosal, as they invade in the living cells on mucosal surfaces. Diagnosis and treatment of the abnormal cells developing in the cervix helps in the prevention of cervical cancer. The two most common tests employed to check the behavior of cervical cells include HPV and Pap tests.

Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-sample/1733

Pap test is a simple smear test, which provides an effective screening measure to determine whether the cervical cells are normal or abnormal. HPV testing is performed to screen for human papillomavirus in the cervix that can lead to cervical cancer. A person observed with abnormal cells through Pap test is recommended to opt for HPV testing for further evaluation of cervical cancer.

Market Dynamics

Rising incidence of chronic diseases such as cervical and vaginal cancer are expected to drive growth of HPV testing and Pap test market over the forecast period. For instance, according to the National Cervical Cancer Coalition 2017, around 12,000 women are diagnosed with cervical cancer each year in the U.S. Moreover, the American Sexual Health Association (ASHA) suggests that cervical cancer is amongst one of the most preventable types of cancer. These cancers can be prevented through early detection and treatment of abnormal cell changes that occurs in the cervix prior to the development of cervical cancer cells.

Moreover, new product launches in improving the existing accuracy of HPV testing is also expected to drive growth of global HPV testing and Pap test market. For instance, in June 2016, QIAGEN N.V launched QIAsure Methylation Test, for determining risk of development of cervical cancer.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1733

Technological advancements in field of diagnostics is also expected to drive the market growth over the forecast period. For instance, in January 2019, Nurx, a consumer health and telemedicine company launched Home HPV Screening test. The new test allows women to conveniently and affordably check their risk for cervical cancer from the comfort of their own home.

However, inaccuracy of smear based Pap test leading to low reliability is expected to hamper growth of the global HPV and Pap testing market.

Regional Insights

On the basis of region, the global HPV testing and Pap test market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global HPV testing and Pap test market over the forecast period. This is attributed to increasing number of cases of cervical cancer in the U.S. For instance in 2016, according to the Centers for Disease Control and Prevention (CDC), around 12,984 new cases of cervical cancer were reported in the U.S.

Moreover, rising awareness about the benefits of early detection of cancer among female population through conduction of various awareness campaigns and government initiatives are expected to fuel growth of the market. For instance, in January 2016, UAB comprehensive care center along with various other non-profit organizations conducted an awareness program that promoted the use of preventive HPV vaccine by explaining the health and precaution benefits achieved from the vaccine to the women in the U.S.

Furthermore, Asia Pacific is expected to witness significant growth in the market over the forecast period, owing to developments in healthcare infrastructure and increasing patient population in developing countries such as India. For instance, according to reports published in the Indian Journal of Medical Research in 2018, cervical carcinoma is one of the most common and dreaded diseases of women, and in India and accounts for approximately 16% of total cervical cancer cases globally.

Competitive Landscape

Key players operating in the global HPV testing and Pap test market include Qiagen N.V., Abbott Laboratories, Becton, Dickinson & Company, Hologic, Inc., Quest Diagnostics, Femasys, Inc., Roche Diagnostics, Arbor Vita Corporation, Onco Health Corporation, Seegene, Inc., and others.

Market players are focused on product approval to sustain their presence in the market. For instance, in April 2019, Hologic, Inc. received the European CE Mark for ThinPrep Genesis processor in Europe. ThinPrep Genesis processor is an automated cytology slide and molecular sample system which allows for accurate and reliable results with increased operational efficiency.

Moreover, in February 2018, Becton, Dickinson and Company received the FDA approval for the BD Onclarity HPV assay, which detects and identifies HPV genotypes that put women at high risk for cervical cancer.

To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/hpv-and-pap-testing-market-1733

Market Taxonomy

On the basis of test type, the global HPV and Pap Testing Market is segmented into:

  • HPV Test
  • Pap Test

On the basis of application, the global HPV and Pap Testing Market is segmented into:

  • Cervical Cancer
  • Vaginal Cancer

On the basis of end-user, the global HPV and Pap Testing Market is segmented into:

  • Hospitals
  • Diagnostic Centers
  • Home Care Settings
  • Others

On the basis of region, the global HPV and Pap Testing Market is segmented into:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 04-Feb-2021